drugset / Trial / NCT03295552
Decitabine Plus Carboplatin in the Treatment of Metastatic TNBC
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the effect of novel DNA demethylating agents in the treatment of metastatic TNBC
Timeline
- Start
- 2017-11-15
- Primary completion
- 2021-06-01
- Completion
- 2021-06-01
Outcome
Outcome not reported
Stopped (Enrollment): “Slow enrollment.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | — | — |
| Subject | Decitabine | Small molecule | 7 mg/m2 | — |